ArticlebioRxiv : the preprint server for biology2026
Early-Enrichment Hit Discovery via Reversible-Work c(t) Estimation in Metadynamics (CTMD).
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Virtual screening for small-molecule binders is often limited by false positives from approximate scoring functions and rigid-receptor assumptions. These can be addressed downstream through accurate but expensive free energy calculations. At the same time, recent artificialintelligence-based co-folding methods have been proposed that claim to achieve accuracy of free energy methods at much lower cost, but these have not yet delivered consistent improvements in early enrichment and can be confounded by memorization. Here we address this gap by introducing c(t)-based metadynamics (CTMD), a physics-based, high-throughput hit-triaging protocol tailored for early enrichment. CTMD uses the nonequilibrium reversible-work estimator c(t) introduced by Tiwary and Parrinello (Journal of Physical Chemistry B, 2015 119 736), computed from a small number of short, independent well-tempered metadynamics trajectories, to rank binding stability without requiring converged binding free energies. Across diverse targets and chemotypes, CTMD provides robust early enrichment while remaining fast, transferable with minimal parameter tuning, and resistant to memorization-driven artifacts-underscoring both an immediately deployable physics-based alternative for screening. For these systems we show how co-folding, particularly Boltz-2, achieves enrichment directly proportional to similairty with training set, and more worrying, even in the presence of signficant modifications to active site. Given its simplicity of implementation, CTMD should thus be an "embarassingly" open-source, early enrichment method available for use by the broad pharma and academic community that sits right between approximate but fast docking or AI based co-folding methods, and more expensive but accurate free energy calculations, expected to lead to saving significant financial and human capital in drug discovery campaigns.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.